A detailed history of Great West Life Assurance CO transactions in Avidity Biosciences, Inc. stock. As of the latest transaction made, Great West Life Assurance CO holds 20,389 shares of RNA stock, worth $850,425. This represents 0.0% of its overall portfolio holdings.

Number of Shares
20,389
Previous 8,652 135.66%
Holding current value
$850,425
Previous $221,000 277.38%
% of portfolio
0.0%
Previous 0.0%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 12, 2024

BUY
$22.73 - $40.85 $266,782 - $479,456
11,737 Added 135.66%
20,389 $834,000
Q3 2023

Nov 14, 2023

BUY
$6.3 - $11.35 $39,557 - $71,266
6,279 Added 264.6%
8,652 $55,000
Q1 2023

May 12, 2023

BUY
$15.35 - $25.65 $7,306 - $12,209
476 Added 25.09%
2,373 $36,000
Q3 2022

Nov 01, 2022

BUY
$15.46 - $23.43 $29,327 - $44,446
1,897 New
1,897 $31,000
Q4 2021

Feb 14, 2022

BUY
$20.4 - $28.66 $19,726 - $27,714
967 Added 103.98%
1,897 $45,000
Q4 2020

Feb 16, 2021

BUY
$24.73 - $35.12 $22,998 - $32,661
930 New
930 $24,000

Others Institutions Holding RNA

About Avidity Biosciences, Inc.


  • Ticker RNA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 52,127,000
  • Market Cap $2.17B
  • Description
  • Avidity Biosciences, Inc., a biopharmaceutical company, engages in the development of oligonucleotide-based therapies. It develops antibody oligonucleotide conjugates (AOC) that are designed to treat a range of serious diseases. The company's lead product candidate AOC 1001 is used for the treatment of myotonic dystrophy type 1, a rare monogenic...
More about RNA
Track This Portfolio

Track Great West Life Assurance CO Portfolio

Follow Great West Life Assurance CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Great West Life Assurance CO , based on Form 13F filings with the SEC.

News

Stay updated on Great West Life Assurance CO with notifications on news.